Meg Brunner, MLIS
Barbosa-Leiker C, et al. Opioid use disorder in women and the implications for treatment. Psychiatric Research and Clinical Practice 2020 (in press).
Published: November 1, 2020
Meg Brunner, MLIS
Lemley SM, et al. Comparing web-based platforms for promoting HIV self-testing and PrEP uptake in high-risk MSM: Protocol for a longitudinal cohort study. JMIR Research Protocols 2020 (in press).
Published: November 1, 2020
Meg Brunner, MLIS
Citation: Winhusen T, et al. Increased morbidity and mortality in hypertensive patients with substance use disorders: Electronic health record findings. Journal of Studies on Alcohol and Drugs 2020;81:471-478.
Published: October 1, 2020
Meg Brunner, MLIS
Citation: Humphreys K, et al. Impact of 12 step mutual help groups on drug use disorder patients in six clinical trials. Drug and Alcohol Dependence 2020;215:108213.
Published: October 1, 2020
Meg Brunner, MLIS
Citation: Matson TE, et al. Cannabis Use, Other Drug Use, and Risk of Subsequent Acute Care in Primary Care Patients. Drug & Alcohol Dependence 2020 (in press).
Published: September 1, 2020
Meg Brunner, MLIS
Killeen TK, et al. Gender and Racial/Ethnic Differences in Physiologic Responses in the Stimulant Reduction Intervention using Dosed Exercise Study. Addictive Behaviors 2020; 110:106546.
Published: September 1, 2020
Meg Brunner, MLIS
Pan Y, et al. The relationship between housing status and substance use and sexual risk behaviors among people currently seeking or receiving services in substance use disorder treatment programs. Journal of Primary Prevention 2020 (in press).
Published: August 4, 2020
Meg Brunner, MLIS
Citation: Cochran G, Bruneau J, Cox N, Gordon AJ. Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic. Substance Abuse 2020;41:3, 269-274.
Published: August 4, 2020
Meg Brunner, MLIS
Peckham AD, et al. Depression history as a predictor of outcomes during buprenorphine-naloxone treatment of prescription opioid use disorder. Drug and Alcohol Dependence 2020 (in press).
Published: July 1, 2020
Meg Brunner, MLIS
Critchley L, et al. Problem opioid use and HIV primary care engagement among hospitalized people who use drugs and/or alcohol. Addiction Science & Clinical Practice 2020;15:19.
Published: July 1, 2020
Meg Brunner, MLIS
Vest NA, et al. Parallel Modeling of Pain and Depression in Prediction of Relapse During Buprenorphine and Naloxone Treatment: A Finite Mixture Model. Drug and Alcohol Dependence 2020;209:107940.
Published: June 1, 2020
Meg Brunner, MLIS
Shulman M, et al. Secondary Analysis of Pain Outcomes in a Large Pragmatic Randomized Trial of Buprenorphine/Naloxone Versus Methadone for Opioid Use Disorder. Journal of Addiction Medicine 2020 (in press).
Published: June 1, 2020
Meg Brunner, MLIS
Citation: Stephens KA, et al. Service utilization and chronic condition outcomes among primary care patients with substance use disorders and co-occurring chronic conditions. Journal of Substance Abuse Treatment 2020;112S:49-55.
Published: May 11, 2020
Meg Brunner, MLIS
Citation: Winhusen T, et al. Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations. Contemporary Clinical Trials 2020;93:106014. Free online.
Published: May 11, 2020
Meg Brunner, MLIS
The current epidemic of opioid misuse and overdose has greatly outpaced the capacity of specialized treatment settings to manage it. A clinical decision support tool for OUD screening, assessment, and treatment within primary care systems may improve healthcare delivery and help address these issues. Further work for adaptation at specific sites and for testing is needed.
Published: March 4, 2020
Meg Brunner, MLIS
Spector AY, Pavlicova M, Hu M, Nunes EV, Campbell ANC, Tross S. Predictors of HIV Sex Risk Behavior Among Women in US Drug Treatment Programs: NIDA CTN Trial Results. Journal of HIV/AIDS & Social Services 2020 (in press).
Published: March 4, 2020
Meg Brunner, MLIS
Mitchell SG, et al. How patient navigators view the use of financial incentives to influence study involvement, substance use, and HIV treatment. Journal of Substance Abuse Treatment 2018;94:18-23.
Published: February 10, 2020
Meg Brunner, MLIS
Harvey L, et al. Psychosocial intervention utilization and substance abuse treatment outcomes in a multisite sample of individuals who use opioids. Journal of Substance Abuse Treatment 2020 (in press).
Published: February 10, 2020
Meg Brunner, MLIS
Citation: Lapham G, et al. Prevalence and Treatment of Opioid Use Disorders Among Primary Care Patients in Six Health Systems. Drug and Alcohol Dependence 2020 (in press)
Published: January 8, 2020
Meg Brunner, MLIS
Citation: Tomko RL, et al. Depressive Symptoms and Cannabis Use in a Placebo-Controlled Trial of N-Acetylcysteine for Adult Cannabis Use Disorder. Psychopharmacology 2019 (in press).
Published: December 5, 2019
Meg Brunner, MLIS
Hoffman KA, et al. Barriers and Facilitators to Recruitment and Enrollment of HIV-Infected Individuals with Opioid Use Disorder in a Clinical Trial. BMC Health Services Research 2019;19:862.
Published: December 5, 2019
Meg Brunner, MLIS
Adam A, et al. Electronic Self-Administered Screening for Substance Use in Adult Primary Care Patients: Feasibility and Acceptability of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (myTAPS) Screening Tool. Addiction Science & Clinical Practice 2019;14:39.
Published: November 14, 2019
Meg Brunner, MLIS
Muzky A, et al. Pharmacists’ Attitudes Toward Dispensing Naloxone and Medications for Opioid Use Disorder: A Scoping Review of the Literature. Substance Abuse 2019 (in press).
Published: November 14, 2019
Meg Brunner, MLIS
Saunders EC, et al. Screening for Substance Use in Rural Primary Care: A Qualitative Study of Providers and Patients. Journal of General Internal Medicine 2019 (in press).
Published: September 6, 2019
